Fluorouracil

tumor protein p53 ; Homo sapiens







354 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34309458 Quercetin and Luteolin Improve the Anticancer Effects of 5-Fluorouracil in Human Colorectal Adenocarcinoma In Vitro Model: A Mechanistic Insight. 2022 2
2 35154466 Synergistic effects of CP-25 and 5-fluorouracil on the hepatocellular carcinoma in vivo and in vitro through regulating activating mitochondrial pathway. 2022 1
3 35191521 ATR inhibitor AZD6738 increases the sensitivity of colorectal cancer cells to 5‑fluorouracil by inhibiting repair of DNA damage. 2022 Apr 1
4 35410287 Single-cell analysis of p53 transitional dynamics unravels stimulus- and cell type-dependent signaling output motifs. 2022 Apr 11 1
5 33240430 Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells. 2021 Jan 1
6 33500399 Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2. 2021 Jan 26 1
7 33564015 Retraction Note: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy. 2021 Feb 9 2
8 33613715 p53 expression confers sensitivity to 5-fluorouracil via distinct chromatin accessibility dynamics in human colorectal cancer. 2021 Mar 5
9 33662352 Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation. 2021 May 5 2
10 33764853 Temporal gene regulation by p53 is associated with the rotational setting of its binding sites in nucleosomes. 2021 Apr 1
11 33798968 Efficient intracellular delivery of p53 protein by engineered protein crystals restores tumor suppressing function in vivo. 2021 Apr 3
12 33906076 Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. 2021 Jun 1
13 34117917 Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer. 2021 Oct 1
14 34151400 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. 2021 Aug 1
15 34279763 The role of SIRT5 and p53 proteins in the sensitivity of colon cancer cells to chemotherapeutic agent 5-Fluorouracil. 2021 Jul 2
16 34452150 Cellulose Nanofiber-Based Hydrogels Embedding 5-FU Promote Pyroptosis Activation in Breast Cancer Cells and Support Human Adipose-Derived Stem Cell Proliferation, Opening New Perspectives for Breast Tissue Engineering. 2021 Aug 1 1
17 34562873 Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. 2021 Nov 1
18 34637097 Quercetin potentiates the chemosensitivity of MCF-7 breast cancer cells to 5-fluorouracil. 2021 Dec 2
19 34794098 Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators. 2021 Dec 1
20 34901834 A narrative review of genetic factors affecting fluoropyrimidine toxicity. 2021 Dec 1
21 34970530 Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation. 2021 1
22 35071232 Deficient or R273H and R248W Mutations of p53 Promote Chemoresistance to 5-FU via TCF21/CD44 Axis-Mediated Enhanced Stemness in Colorectal Carcinoma. 2021 2
23 35096810 Down-Regulating HAUS6 Suppresses Cell Proliferation by Activating the p53/p21 Pathway in Colorectal Cancer. 2021 1
24 30693808 Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells. 2020 Apr 2
25 31518438 BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers. 2020 Feb 2
26 31897925 Management of sinonasal adenocarcinomas with anterior skull base extension. 2020 Dec 1
27 31898732 Cooperation of SRPK2, Numb and p53 in the malignant biology and chemosensitivity of colorectal cancer. 2020 Jan 31 1
28 31903119 Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer. 2020 1
29 31923958 UV-light cross-linked and pH de-cross-linked coumarin-decorated cationic copolymer grafted mesoporous silica nanoparticles for drug and gene co-delivery in vitro. 2020 Mar 3
30 31938994 iASPP-Mediated ROS Inhibition Drives 5-Fu Resistance Dependent on Nrf2 Antioxidative Signaling Pathway in Gastric Adenocarcinoma. 2020 Oct 2
31 31969973 Inhibition of protein FAK enhances 5-FU chemosensitivity to gastric carcinoma via p53 signaling pathways. 2020 1
32 32194724 Involvement of ribosomal protein L11 expression in sensitivity of gastric cancer against 5-FU. 2020 Mar 3
33 32457882 β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest. 2020 5
34 32731241 The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 2020 1
35 32742376 TP53 mutation influences the efficacy of treatment of colorectal cancer cell lines with a combination of sirtuin inhibitors and chemotherapeutic agents. 2020 Aug 1
36 32782527 Konjac glucomannan reverses multi-drug resistance of HepG2/5-FU cells by suppressing AKT signaling and increasing p53 expression. 2020 Sep 1
37 33005290 Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids. 2020 Sep 15 1
38 33087710 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. 2020 Oct 21 4
39 33389946 Combined Effects of Protocatechuic Acid and 5-Fluorouracil on p53 Gene Expression and Apoptosis in Gastric Adenocarcinoma Cells. 2020 Dec 23 4
40 30488540 Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells. 2019 Feb 5
41 30723502 Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells. 2019 1
42 30770552 Mechanism of bioactive polysaccharide from Lachnum sp. acts synergistically with 5-fluorouracil against human hepatocellular carcinoma. 2019 Feb 15 1
43 31002510 Fuplatin: An Efficient and Low-Toxic Dual-Prodrug. 2019 May 9 1
44 31042625 Epigenetically Down-Regulated Acetyltransferase PCAF Increases the Resistance of Colorectal Cancer to 5-Fluorouracil. 2019 Jun 1
45 31366086 Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. 2019 Jul 30 2
46 31544060 Activation of p53 Gene Expression and Synergistic Antiproliferative Effects of 5-Fluorouracil and β-escin on MCF7 Cells. 2019 Jul-Sep 3
47 31569395 N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor. 2019 Sep 28 1
48 31592435 Synergetic Impact of Combined 5-Fluorouracil and Rutin on Apoptosis in PC3 Cancer Cells through the Modulation of P53 Gene Expression. 2019 Aug 3
49 27871087 The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1. 2018 3
50 29138869 Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1. 2018 Jan 1